Vyne Therapeutics Inc. (VYNE)
NASDAQ · Healthcare
Vyne Therapeutics Inc. Operating Income 2016–2025
Vyne Therapeutics Inc. annual/quarterly operating income history and growth rate from 2016 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Vyne Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -3.8 M, a 58.51% decrease year-over-year.
- Vyne Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -33.6 M, a 1.99% decrease year-over-year.
- Vyne Therapeutics Inc. annual operating income for 2025 was -29.7 M, a 31.83% decrease from 2024.
- Vyne Therapeutics Inc. annual operating income for 2024 was -43.6 M, a 49.15% increase from 2023.
- Vyne Therapeutics Inc. annual operating income for 2023 was -29.3 M, a 14.69% decrease from 2022.
- Vyne Therapeutics Inc. annual operating income for 2022 was -34.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Vyne Therapeutics Inc. Operating Income — FAQ
Vyne Therapeutics Inc. (VYNE) operating income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Vyne Therapeutics Inc.'s operating income?
Vyne Therapeutics Inc. (VYNE) reported operating income of -$30M for fiscal 2025.
Where can I see VYNE's operating income history?
The chart and table above show Vyne Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.